INTERNATIONAL PATENT: KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. FILES APPLICATION FOR "IMIDAZOLINONE DERIVATIVE COMBINED WITH PD-1 OR PD-L1 INHIBITOR FOR USE IN THE TREATMENT OF TUMORS"

GENEVA, Sept. 29 -- KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (4th Floor, Building 2, No. 319, Tsingtao Brewery AvenueWenjiang DistrictChengdu City, Sichuan) filed a patent application (PCT/IB2025/052895) for "IMIDAZOLINONE DERIVATIVE COMBINED WITH PD-1 OR PD-L1 INHIBITOR FOR USE IN THE TREATMENT OF TUMORS" on Mar 19, 2025. With publication no. WO/2025/196671, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEI, Yonggang (c/o Kangbaida (Sichuan) Biotechnology Co., Ltd.4th Floor, Building 2, No. 319, Tsingtao Brewery Ave...